Hubacek JA - Search Results

1

Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.

Dorfmeister B, Zeng WW, Dichlberger A, Nilsson SK, Schaap FG, Hubacek JA, Merkel M, Cooper JA, Lookene A, Putt W, Whittall R, Lee PJ, Lins L, Delsaux N, Nierman M, Kuivenhoven JA, Kastelein JJ, Vrablik M, Olivecrona G, Schneider WJ, Heeren J, Humphries SE, Talmud PJ. Dorfmeister B, et al. Among authors: hubacek ja. Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1866-71. doi: 10.1161/ATVBAHA.108.172866. Epub 2008 Jul 17. Arterioscler Thromb Vasc Biol. 2008. PMID: 18635818

2

APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels.

Hubacek JA, Wang WW, Skodová Z, Adámková V, Vráblík M, Horínek A, Stulc T, Ceska R, Talmud PJ. Hubacek JA, et al. Clin Chem Lab Med. 2008;46(6):773-7. doi: 10.1515/CCLM.2008.160. Clin Chem Lab Med. 2008. PMID: 18601597

3

Plasma levels of remnant particles are determined in part by variation in the APOC3 gene insulin response element and the APOCI-APOE cluster.

Waterworth DM, Hubacek JA, Pitha J, Kovar J, Poledne R, Humphries SE, Talmud PJ. Waterworth DM, et al. Among authors: hubacek ja. J Lipid Res. 2000 Jul;41(7):1103-9. J Lipid Res. 2000. PMID: 10884292 Free article.

4

Genetic determination of plasma lipids and insulin in the Czech population.

Hubacek JA, Waterworth DM, Poledne R, Pitha J, Skodová Z, Humphries SE, Talmud PJ. Hubacek JA, et al. Clin Biochem. 2001 Mar;34(2):113-8. doi: 10.1016/s0009-9120(01)00184-9. Clin Biochem. 2001. PMID: 11311220

5

Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in the Czech population.

Hubácek JA, Waterworth DM, Pitha J, Humphries SE, Talmud PJ, Poledne R. Hubácek JA, et al. Physiol Res. 2001;50(4):345-51. Physiol Res. 2001. PMID: 11551139 Free article.

6

Effect of apolipoprotein E polymorphism on statin-induced decreases in plasma lipids and cardiovascular events.

Hubacek JA, Vrablik M. Hubacek JA, et al. Drug Metabol Drug Interact. 2011;26(1):13-20. doi: 10.1515/DMDI.2011.107. Drug Metabol Drug Interact. 2011. PMID: 21557673 Review.

7

New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels.

Hubácek JA, Adámková V, Ceska R, Poledne R, Horínek A, Vráblík M. Hubácek JA, et al. Physiol Res. 2004;53(2):225-8. Physiol Res. 2004. PMID: 15046561 Free article.

8

Genetic predisposition of human plasma triglyceride concentrations.

Schwarzova L, Hubacek JA, Vrablik M. Schwarzova L, et al. Among authors: hubacek ja. Physiol Res. 2015;64(Suppl 3):S341-54. doi: 10.33549/physiolres.933197. Physiol Res. 2015. PMID: 26680667 Free article. Review.

9

Apolipoprotein A5 in health and disease.

Hubáček JA, Adámková V, Vrablík M, Kadlecová M, Zicha J, Kunes J, Pitha J, Suchánek P, Poledne R. Hubáček JA, et al. Physiol Res. 2009;58 Suppl 2:S101-S110. doi: 10.33549/physiolres.931911. Physiol Res. 2009. PMID: 20131928 Free article. Review.

10

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.

Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration; Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, et al. Lancet. 2010 May 8;375(9726):1634-9. doi: 10.1016/S0140-6736(10)60545-4. Lancet. 2010. PMID: 20452521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters